Axios Visuals The emergence of groundbreaking weight-loss drugs is transforming how Americans shed pounds, including in Washington state. The big picture: Nearly 18 million Americans are expected to ...

Shaelyn Weaver, after struggling with weight issues due to PCOS and pre-diabetes, embarked on a significant weight loss ...

Users of GLP-1 drugs in the US cut their grocery spending by an average of 5.5% in the six months after taking the medication, a study shows.

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates ...

Ozempic was originally approved to treat people with Type 2 diabetes, but demand has surged because of the drug’s weight-loss ...

Just eight seconds into the start of the 2025 award show season, Nikki Glaser, the host of the 82nd Golden Globes, dubbed the ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Serena Williams has recently been garnering attention with her noticeably slimmer figure, sparking curiosity among fans about ...

Food manufacturers are trying to whip themselves up a forkful of the slimming trend — but nutrition experts aren’t giving them a good review.

Novo Nordisk's prospects look attractive despite a recent clinical setback. AstraZeneca would be performing well if not for ...

Nina King says that Ozempic's rise could shift beauty standards away from thinness as it becomes more accessible.

Our broken food system is ultimately at the center of the nation's obesity numbers and must be addressed.